Perminova Names Business, Science and Academic Leader Gail Naughton to Board of Advisors

Share Article

Perminova, developer of web-based software for the nation’s leading cardiology centers, announced that Gail K. Naughton, Ph.D., a leader in business, finance, biomedicine and academia, has joined the Perminova Board of Advisors. Naughton is currently CEO and Chairman of Histogen, Inc., a regenerative medicine company she founded in 2007 to develop novel treatments for conditions ranging from hair loss to cancer. Naughton was Dean of the College of Business Administration at San Diego State University, a position she held for nine years.

Gail Naughton, CEO and Chairman of Histogen, Inc. and former Dean of the College of Business Administration at San Diego State University, was named Advisory Board member for Perminova.

“An Advisor the caliber of Gail Naughton brings tremendous benefit to Perminova,” said Craig K. Collins, President & CEO of Perminova. “Her breadth of knowledge and experience in medical research, industry and academia is remarkable."

Perminova, developer of web-based software for the nation’s leading cardiology centers, announced that Gail K. Naughton, Ph.D., a leader in business, finance, biomedicine and academia, has joined the Perminova Board of Advisors.

Naughton is currently CEO and Chairman of Histogen, Inc., a regenerative medicine company she founded in 2007 to develop novel treatments for conditions ranging from hair loss to cancer. She also serves as a Director for C.R. Bard, Inc., a global company whose Electrophysiology Division develops diagnostic devices for treating cardiac arrhythmias. Previously, Naughton was Dean of the College of Business Administration at San Diego State University, a position she held for nine years. She was the first female biotechnology entrepreneur to lead a major U.S. business school. At SDSU, Naughton was part of an administration that dramatically boosted the school’s academic performance and reputation.

“An Advisor the caliber of Gail Naughton brings tremendous benefit to Perminova,” said Craig K. Collins, President & CEO of Perminova. “Her breadth of knowledge and experience in medical research, industry and academia is remarkable. She will provide invaluable expertise as Perminova expands operations and launches new products in the health technology market.”

Prior to joining San Diego State, Naughton was a respected scientist and executive, with an accomplished background in the field of tissue engineering. She co-founded Advanced Tissue Sciences in 1986, serving as Principal Scientist before rising to Executive VP, Chief Scientific Officer, and then President and Chief Operating Officer. At Advanced Tissue Sciences, she was Co-Inventor of the company’s core technology, and oversaw the design and development of the world's first up-scaled manufacturing facility for tissue-engineered products. Naughton held professorships at City University of New York, Hunter College and York College. She also was Assistant Professor of Research at New York University Medical Center.

Naughton holds over 95 U.S. and foreign patents and is extensively published in the field of tissue engineering. In 2000, she received the 27th Annual National Inventor of the Year award by the Intellectual Property Owners Association in honor of her pioneering work in the field of tissue engineering. Naughton is co-author of “Patents in the Knowledge-Based Economy,” published in 2003 by the National Research Council of the National Academic Press, and she served on the National Academy Committee for Patent Reform.

She is an Advisory Board member of the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Institute of Technology, and a member of the Board of Directors for the Ackerman Foundation. Naughton received the ARCS Foundation’s National Scientist of the Year award in 1998 and the Lindbergh-Carrel Prize in 2002, and was named Woman of the Year by San Diego Magazine in 2006.

Naughton earned a BS from St. Francis College, Brooklyn, New York, and both an MS in Histology and a Ph.D. in Hematology from New York University Medical Center. She also holds an MBA in Executive Management from the Anderson School at UCLA.

About Perminova

La Jolla, Calif.-based Perminova develops and markets web-based software for use in cardiovascular surgery. The company is pioneering healthcare’s move from outdated client-server technology to modern, secure cloud computing. Perminova offers customers Software-as-a-Service (SaaS), allowing them to take full advantage of a surgical information system that’s more robust, flexible and cost-effective than currently available. In 2011, the company released Perminova EP, a software module that manages the scheduling, workflow and billing that occur before, during and after cardiac electrophysiological (EP) procedures. Perminova EP enables doctors, nurses and administrators to realize enhanced charge-capture, efficiency and patient safety. The software is currently deployed at leading cardiology centers throughout the United States, including UC San Diego Health System and Mount Sinai Hospital in New York.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Eileen Lane

Jim Gogek
Perminova
866-584-5884 109
Email >
Visit website